Hasandalan, Eddie L.

HRN: 28-60-02  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/17/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/17/2026
02/24/2026
IV
500MG
Q8
PNEUMOPERITONEUM
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: